-
Use of an intravenous chelation regimen with disodium EDTA, compared with placebo, modestly reduced the risk of adverse cardiovascular outcomes in stable patients with a history of myocardial infarction (MI). These results do not support the routine use of chelation therapy for treatment of patients who have had a prior MI.
-
This meta-analysis did not convincingly demonstrate a positive effect of gastric acid-suppressing treatment in patients with chronic cough.
-
-
More than 95% of shoulder dislocations are anterior in location.
Pre- and post-reduction radiographs are not required in patients with chronic recurrent dislocations who have dislocations with minor or no trauma.
Leverage reduction techniques may be able to reduce the dislocation without the need for opiates or sedatives.
Post-reduction immobilization is primarily done for patient comfort, not to reduce the risk of recurrent dislocation.
-
Optimism is associated with a significantly healthier lipid profile than is present in less optimistic persons, possibly due to healthier behaviors and lower body mass indices, which are found with increased frequency in optimistic individuals.
-
A new product has been approved for the urgent reversal of warfarin or other vitamin K antagonists anticoagulation in the setting of acute bleeding. This human plasma-derived product contains vitamin K-dependent coagulation Factors II, VII, IX, and X as well as antithrombotic Protein C and Protein S. It is heat-treated and viral filtered. Prothrombin complex concentrate (PCC) is manufactured by CSL Behring GmbH in Germany and marketed by CSL Behring LLC as Kcentra. The product has been licensed in Germany since 1996.
-
-
-
Five days of steroid treatment was as effective as 14 days of treatment in preventing repeat exacerbations of COPD in patients presenting to the emergency department with COPD exacerbations.
-
The injection of a dextrose solution in and around the knee (prolotherapy) is an alternative treatment for the pain of knee osteoarthritis. A randomized, controlled trial shows that prolotherapy is effective for long-term control of knee pain and improvement in knee function.
